Immunotherapy: CAR T cells ready to go mainstream.
Diana
D
Romero
D003520:Cyclophosphamide / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007167:Immunotherapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
C000605956:CD19-specific chimeric antigen receptor; D011948:Receptors, Antigen, T-Cell; D003520:Cyclophosphamide